Pulmonary Carcinoid Tumor Recruiting Phase 2 Trials for DB08896 (Regorafenib)

Also known as: Carcinoid tumour pulmonary / Carcinoid tumor of lung / Pulmonary carcinoid tumour

IndicationStatusPhase
DBCOND0028853 (Pulmonary Carcinoid Tumor)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02259725Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine TumorsTreatment